1784 related articles for article (PubMed ID: 19208365)
1. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
2. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
Li Z; Mizuno S; Nakamura T
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
Wang H; Vohra BP; Zhang Y; Heuckeroth RO
Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
[TBL] [Abstract][Full Text] [Related]
5. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
[TBL] [Abstract][Full Text] [Related]
9. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
[TBL] [Abstract][Full Text] [Related]
10. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.
Shigekawa M; Takehara T; Kodama T; Hikita H; Shimizu S; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Hayashi N
Biochem Biophys Res Commun; 2011 Mar; 406(4):614-20. PubMed ID: 21356197
[TBL] [Abstract][Full Text] [Related]
11. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
[TBL] [Abstract][Full Text] [Related]
12. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
13. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA
Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
[TBL] [Abstract][Full Text] [Related]
15. Potent antioxidant role of pirfenidone in experimental cirrhosis.
Salazar-Montes A; Ruiz-Corro L; López-Reyes A; Castrejón-Gómez E; Armendáriz-Borunda J
Eur J Pharmacol; 2008 Oct; 595(1-3):69-77. PubMed ID: 18652820
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
[TBL] [Abstract][Full Text] [Related]
17. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
[TBL] [Abstract][Full Text] [Related]
18. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
Wang H; Zhang Y; Heuckeroth RO
Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
[TBL] [Abstract][Full Text] [Related]
19. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
Moransard M; Sawitzky M; Fontana A; Suter T
Glia; 2010 Apr; 58(5):559-71. PubMed ID: 19941340
[TBL] [Abstract][Full Text] [Related]
20. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.
Canbay A; Feldstein AE; Higuchi H; Werneburg N; Grambihler A; Bronk SF; Gores GJ
Hepatology; 2003 Nov; 38(5):1188-98. PubMed ID: 14578857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
